A
ASMB
Assembly Bioscie
25.91
+0.36+1.41%After Hours: 25.91 0.00 0.00%16:10 07/27 EDT
OPEN/PREV CLOSE25.80/25.55
TODAY RANGE25.80-26.57
VOL79.18K
MARKET CAP513.46M
52 WEEK RANGE16.90-39.71
AVG VOL (3M)211.24K
% TURNOVER0.40%
TURNOVER--
P/E (TTM)-20.0837
% RANGE2.78%
EPS(TTM)-1.2901
P/E(FORWARD)-15.9938
P/B2.073
BVPS12.50
DIVIDEND--
P/S5.68
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP363.67M
SHARES OUTSTANDING19.82M
NEXT EARNINGS08/04-08/10
FREE FLOAT14.04M
LOT SIZE1
EX-DATE02/12/2024
News
Press Releases
Financial Reports
Profile
Seeking Alpha·06/26 20:59
Health Care had the best week vs. the S&P 500 on record
Dow Jones·06/15 17:27
Assembly Biosciences Is Maintained at Outperform by Mizuho
Benzinga·06/15 17:17
Mizuho Maintains Outperform on Assembly Biosciences, Raises Price Target to $45
TipRanks·06/15 11:07
Assembly Biosciences price target raised to $45 from $40 at Mizuho
Reuters·06/15 07:49
U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
TipRanks·06/12 19:15
Mizuho Securities Keeps Their Buy Rating on Assembly Biosciences (ASMB)
TipRanks·06/05 21:20
Assembly Biosciences Expands Equity Plans, Reelects Board
TipRanks·06/04 00:26
H.C. Wainwright Reaffirms Their Buy Rating on Assembly Biosciences (ASMB)
Dow Jones·05/28 13:41
Assembly Biosciences Price Target Maintained With a $43.00/Share by Guggenheim
Benzinga·05/28 13:31
Guggenheim Reiterates Buy on Assembly Biosciences, Maintains $43 Price Target
TipRanks·05/28 11:36
Guggenheim Sticks to Their Buy Rating for Assembly Biosciences (ASMB)
Same Industry
Name/Symbol
Change%
Price